https://www.naturalhealthhaven.net and will be shipped directly to you.
Here is some information regarding this product that I am currently taking to help boost my Immunity and assist me in staying healthy during these challenging times.
"We now have a Palmitoylethanolamide (PEA) & Alpha-lipoic acid (ALA) formula... Nerve Eze. As is pointed out in the information below, Nerve Eze is not only a very effective, safe, non-addictive pain reliever / anti-inflammatory, but also a potent immune system regulator with documented applications for the flu and respiratory infections due to its documented efficacy and more importantly its very benign side effect profile."
~ Carl Neubauer (Functional Medicine consultant at Nutri-Dyn)
Palmitoylethanolamide (PEA)(as found in the formula Nerve Eze)With over 350 peer reviewed papers and a Nobel Prize all devoted to Palmitoylethanolamide (PEA) and its many indications, it’s a remarkably under-appreciated molecule.PEA’s effects are greatly based on its affecting the endocannabinoid system, but they are not limited to the endocannabinoid pathway. (7, 18)Palmitoylethanolamide (PEA) is a safe, non-addictive pain reliever, anti-inflammatory and immune system regulator. There is no overdose level with PEA, no records of addiction, no side effects or allergic reactions and no negative interactions with drugs. PEA is efficient, safe, can be used alongside drugs. (12)The fatty acid amide called palmitoylethanolamide (PEA), is an endogenous nuclear factor agonist which affects several different nuclear receptors, either by binding to them directly, or through “entourage effect”. (1, 2, 8, 10, 14)PEA plays a major role in reducing chronic pain and excessive inflammation, but also in regulating immune response and feeding. (3, 4, 6, 7, 9, 11, 12, 13, 17, 24) A great advantage of PEA is that it does not mask the pain, but it actually works to remove its source.
Published research documents a significantly favorable outcome of "Palmitoylethanolamide (PEA)” in acute respiratory disease / influenza / viral infection. PEA was marketed for the treatment of influenza as prophylaxis and treatment for the common cold under the brand name Impulsin in the 1960’s and 1970’s.According to a review of published studies in the Int J Inflam. 2013; 2013:
"Given the results of 6 clinical trials in flu and the common cold… PEA should be reconsidered by clinicians as a new treatment modality for the flu and respiratory infections due to its documented efficacy and more importantly its very benign side effect profile. ...the ease of application of PEA offers the possibility to have a quick therapeutic answer ready in case of a flu epidemic, especially in cases of a mismatch between circulating strains and the recommendations from WHO.”
"Endogenous and dietary lipids such as palmitoylethanolamide (PEA) contribute to the maintenance of homeostasis including modulation of the immune response (14). ... The eCB system regulates the body's inflammatory response, and particularly in the central nervous system (CNS), it modulates microglial activation.”Reference: Front. Immunol., 16 November 2018 | https://doi.org/10.3389/fimmu.2018.02671- Prophylactic Palmitoylethanolamide Prolongs Survival and Decreases Detrimental Inflammation in Aged Mice With Bacterial Meningitis
Research suggests that the ingredients in Nerve Eze (Palmitoylethanolamide (PEA) & Alpha-lipoic acid (ALA):
- Support healthy inflammatory response and and provides "analgesic actions “ on pain
- Support healthy nerve function and regeneration
- Support healthy joint function by promoting flexibility and comfort
- Promote healthy functioning of the endocannabinoid system
- Support a healthy immune response with applications in acute respiratory disease / influenza / viral infection.
- Support restful sleep and relaxation from PEA’s calming effects on neurological pathways
- Promote positive measures of quality of life
The dose is generally 1 capsule twice daily.Suggested Retail Cost is $44.75 for 60 capsule bottle.Catalog Code is R184
References:
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573364/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597234/
[3] https://www.ncbi.nlm.nih.gov/pubmed/18602217
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/
[5] https://www.dovepress.com/palmitoylethanolamide-a-neutraceutical-in-nerve-compression-syndromes--peer-reviewed-article-JPR
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094513/
[7] https://www.ncbi.nlm.nih.gov/pubmed/15465922
[8] https://www.ncbi.nlm.nih.gov/pubmed/12031775
[9] https://www.ncbi.nlm.nih.gov/pubmed/11426841
[10] https://www.ncbi.nlm.nih.gov/pubmed/9685157
[11] https://www.ncbi.nlm.nih.gov/pubmed/8739213
[12] https://www.ncbi.nlm.nih.gov/pubmed/26815246
[13] https://www.ncbi.nlm.nih.gov/pubmed/22343363
[14] https://www.ncbi.nlm.nih.gov/pubmed/18602217
[15] https://www.ncbi.nlm.nih.gov/pubmed/13211905
[16] https://www.ncbi.nlm.nih.gov/pubmed/24952959
[17] https://www.ncbi.nlm.nih.gov/pubmed/24844438
[18] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878779/
[19] https://www.ncbi.nlm.nih.gov/pubmed/22558609
[20] https://www.ncbi.nlm.nih.gov/pubmed/25934566
[21] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171547/
[22] https://www.ncbi.nlm.nih.gov/pubmed/11985831
[23] https://www.ncbi.nlm.nih.gov/pubmed/15497675
[24] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751869/
[25] https://www.ncbi.nlm.nih.gov/pubmed/18657182
[26] https://www.ncbi.nlm.nih.gov/pubmed/17712833
[27] https://www.ncbi.nlm.nih.gov/pubmed/19009545
[28] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528830/
[29] https://www.ncbi.nlm.nih.gov/pubmed/19282326
[30] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095107/
[31] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737440/
[32] https://www.ncbi.nlm.nih.gov/pubmed/15027802
No comments:
Post a Comment